| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Journal of Lipid Research, Vol 32, 1993-2000, Copyright © 1991 by Lipid Research, Inc.
ARTICLES |
WJ Johnson, EP Kilsdonk, A van Tol, MC Phillips and GH Rothblat
Department of Physiology and Biochemistry, Medical College of Pennsylvania, Philadelphia 19129.
Using immunoaffinity chromatography, we separated human high density lipoprotein (HDL) into two subfractions: LP-AI, in which all particles contain apolipoprotein A-I (apoA-I) but no apoA-II, and LP-AI/AII, in which all particles contain both apoA-I and apoA-II. To compare LP-AI and LP-AI/AII as acceptors of cell cholesterol, the isolated subfractions were diluted to 50 micrograms phospholipid/ml, and then incubated with monolayer cultures of cells in which whole-cell and lysosomal cholesterol has been labeled with 14C and 3H, respectively. We used three cell types (Fu5AH rat hepatoma cells, normal human skin fibroblasts, and rabbit aortic smooth muscle cells). When these cells were prepared to contain normal physiological quantities of cholesterol (20-35 micrograms/mg protein), LP-AI and LP-AI/AII were nearly equally efficient in promoting efflux of both whole-cell and lysosomal cholesterol. For whole-cell cholesterol, the rate constants for efflux to LP-AI and LP-AI/AII were: 0.050/h and 0.053/h, respectively, with Fu5AH cells; 0.0063/h and 0.0074/h with GM3468 human skin fibroblasts; and 0.0076/h and 0.0079/h with rabbit aortic smooth muscle cells. When cholesterol in hepatoma cells or fibroblasts was elevated two- to threefold above normal, there was still not difference in efflux of whole-cell cholesterol to LP-AI and LP-AI/AII. In longterm incubations, the net depletion of cholesterol mass from cholesterol-enriched cells was either identical with the two HDL subfractions, or somewhat greater with LP-AI/AII.(ABSTRACT TRUNCATED AT 250 WORDS)
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  D. Sahoo, T. C. Trischuk, T. Chan, V. A. B. Drover, S. Ho, G. Chimini, L. B. Agellon, R. Agnihotri, G. A. Francis, and R. Lehner ABCA1-dependent lipid efflux to apolipoprotein A-I mediates HDL particle formation and decreases VLDL secretion from murine hepatocytes J. Lipid Res., June 1, 2004; 45(6): 1122 - 1131. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. H. Rothblat, M. de la Llera-Moya, V. Atger, G. Kellner-Weibel, D. L. Williams, and M. C. Phillips Cell cholesterol efflux: integration of old and new observations provides new insights J. Lipid Res., May 1, 1999; 40(5): 781 - 796. [Abstract] [Full Text]
|
|
|
|
 |
|
 W. A. Boisvert, A. S. Black, and L. K. Curtiss ApoA1 Reduces Free Cholesterol Accumulation in Atherosclerotic Lesions of ApoE–Deficient Mice Transplanted With ApoE–Expressing Macrophages Arterioscler. Thromb. Vasc. Biol., March 1, 1999; 19(3): 525 - 530. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. H. Fidge High density lipoprotein receptors, binding proteins, and ligands J. Lipid Res., February 1, 1999; 40(2): 187 - 201. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Benvenga and J. Robbins Thyroid Hormone Efflux from Monolayer Cultures of Human Fibroblasts and Hepatocytes. Effect of Lipoproteins and Other Thyroxine Transport Proteins Endocrinology, October 1, 1998; 139(10): 4311 - 4318. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F.-Y. Jin, V. S. Kamanna, and M. L. Kashyap Estradiol Stimulates Apolipoprotein A-I– but Not A-II–Containing Particle Synthesis and Secretion by Stimulating mRNA Transcription Rate in Hep G2 Cells Arterioscler. Thromb. Vasc. Biol., June 1, 1998; 18(6): 999 - 1006. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Fournier, J.-L. Paul, V. Atger, A. Cogny, T. Soni, M. de la Llera-Moya, G. Rothblat, and N. Moatti HDL Phospholipid Content and Composition as a Major Factor Determining Cholesterol Efflux Capacity From Fu5AH Cells to Human Serum Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 2685 - 2691. [Abstract] [Full Text]
|
|
|
|
|
|
H. E. Miettinen, M. Jauhiainen, H. Gylling, S. Ehnholm, A. Palomaki, T. A. Miettinen, and K. Kontula Apolipoprotein A-IFIN (Leu159->Arg) Mutation Affects Lecithin : Cholesterol Acyltransferase Activation and Subclass Distribution of HDL but Not Cholesterol Efflux From Fibroblasts Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 3021 - 3032. [Abstract] [Full Text]
|
|
|
|
|
|
M. Tilly-Kiesi, A. H. Lichtenstein, J. M. Ordovas, G. Dolnikowski, R. Malmstrom, M.-R. Taskinen, and E. J. Schaefer Subjects With ApoA-I(Lys107->0) Exhibit Enhanced Fractional Catabolic Rate of ApoA-I in Lp(AI) and ApoA-II in Lp(AI With AII) Arterioscler. Thromb. Vasc. Biol., May 1, 1997; 17(5): 873 - 880. [Abstract] [Full Text]
|
|
|
|
 |
|
 Y. Zhao, D. L. Sparks, and Y. L. Marcel Specific Phospholipid Association with Apolipoprotein A-I Stimulates Cholesterol Efflux from Human Fibroblasts. STUDIES WITH RECONSTITUTED SONICATED LIPOPROTEINS J. Biol. Chem., October 11, 1996; 271(41): 25145 - 25151. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F.-Y. Jin, V. S. Kamanna, M.-Y. Chuang, K. Morgan, and M. L. Kashyap Gemfibrozil Stimulates Apolipoprotein A-I Synthesis and Secretion by Stabilization of mRNA Transcripts in Human Hepatoblastoma Cell Line (Hep G2) Arterioscler. Thromb. Vasc. Biol., August 1, 1996; 16(8): 1052 - 1062. [Abstract] [Full Text]
|
|
|
|
|
|
H.-O. Mowri, J. R. Patsch, A. M. Gotto Jr, and W. Patsch Apolipoprotein A-II Influences the Substrate Properties of Human HDL2 and HDL3 for Hepatic Lipase Arterioscler. Thromb. Vasc. Biol., June 1, 1996; 16(6): 755 - 762. [Abstract] [Full Text]
|
|
|
|
|
|
K. Takata, K. Saku, T. Ohta, M. Takata, H. Bai, S. Jimi, R. Liu, H. Sato, G. Kajiyama, and K. Arakawa A New Case of ApoA-I Deficiency Showing Codon 8 Nonsense Mutation of the ApoA-I Gene Without Evidence of Coronary Heart Disease Arterioscler. Thromb. Vasc. Biol., November 1, 1995; 15(11): 1866 - 1874. [Abstract] [Full Text]
|
|
|
|
|
|
W. J. Johnson, R. T. Fischer, M. C. Phillips, and G. H. Rothblat Efflux of Newly Synthesized Cholesterol and Biosynthetic Sterol Intermediates from Cells J. Biol. Chem., October 20, 1995; 270(42): 25037 - 25046. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Syvanne, J. Kahri, K. S. Virtanen, and M.-R. Taskinen HDLs Containing Apolipoproteins A-I and A-II (LpA-I:A-II) as Markers of Coronary Artery Disease in Men With Non–Insulin- Dependent Diabetes Mellitus Circulation, August 1, 1995; 92(3): 364 - 370. [Abstract] [Full Text]
|
|
|
|
|
|
L. Lagrost, C. Dengremont, A. Athias, C. d. Geitere, J.-C. Fruchart, C. Lallemant, P. Gambert, and G. Castro Modulation of Cholesterol Efflux from Fu5AH Hepatoma Cells by the Apolipoprotein Content of High Density Lipoprotein Particles J. Biol. Chem., June 2, 1995; 270(22): 13004 - 13009. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Clevidence, M. E. Reichman, J. T. Judd, R. A. Muesing, A. Schatzkin, E. J. Schaefer, Z. Li, J. Jenner, C. C. Brown, M. Sunkin, et al. Effects of Alcohol Consumption on Lipoproteins of Premenopausal Women : A Controlled Diet Study Arterioscler. Thromb. Vasc. Biol., February 1, 1995; 15(2): 179 - 184. [Abstract] [Full Text]
|
|
|
|
|
|
T. O'Brien, T. T. Nguyen, B. J. Hallaway, D. Hodge, K. Bailey, D. Holmes, and B. A. Kottke The Role of Lipoprotein A-I and Lipoprotein A-I/A-II in Predicting Coronary Artery Disease Arterioscler. Thromb. Vasc. Biol., February 1, 1995; 15(2): 228 - 231. [Abstract] [Full Text]
|
|
|
|
|
|
S. Sonda, L.-M. Ting, S. Novak, K. Kim, J. J. Maher, R. V. Farese Jr., and J. D. Ernst Cholesterol Esterification by Host and Parasite Is Essential for Optimal Proliferation of Toxoplasma gondii J. Biol. Chem., September 7, 2001; 276(37): 34434 - 34440. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |
